University of Bristol study finds unexpected physical cause of depression

Researchers at the University of Bristol have discovered that depression may be linked to inflammation in the body, not just brain chemistry. The study suggests that targeting the immune system could help patients who don't respond to conventional antidepressants. This discovery could fundamentally change how depression is treated.

Researchers at the University of Bristol have made a breakthrough discovery in the field of depression – according to new research, one significant cause of the condition may be inflammation in the body, rather than merely a chemical imbalance in the brain. This finding could mark a turning point in treating depression for millions of people struggling with the condition worldwide.

A new approach to treatment

Previous treatment approaches have focused mainly on regulating levels of neurotransmitters such as serotonin and dopamine. However, the Bristol research shows that targeting the immune system and inflammatory processes could provide relief particularly for patients who have never benefited from conventional antidepressants.

Globally, it is estimated that a large proportion of depression patients do not respond to existing medications – according to some estimates, up to one-third of cases. The results of the Bristol study offer hope to these people, providing an entirely new direction for treatment.

What this means for the future

Researchers emphasise that while the results are promising, additional clinical trials are needed before new anti-inflammatory treatment approaches can enter wider clinical practice. Over the coming years, large-scale studies are expected, which should determine which patients would benefit most from such treatment.